CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Foxo Technologies Inc is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Foxo Technologies Inc
729 Washington Ave. N, Suite 600
Phone: (612) 562-9447p:612 562-9447 MINNEAPOLIS, MN  55401  United States Ticker: FOXOFOXO

Business Summary
FOXO Technologies Inc. is engaged in commercializing epigenetic biomarker technology to support groundbreaking scientific research and next-generation business initiatives. The Company owns and operates three subsidiaries: Foxo Labs, Inc., Myrtle Recovery Centers, Inc., and Rennova Community Health, Inc. It applies automated machine learning and artificial intelligence (AI) technologies to discover epigenetic biomarkers of human health, wellness and aging. Its segments include Healthcare and Labs and Life. The Healthcare segment offers behavioral health services, including substance abuse treatment. Services are provided on either an inpatient, residential basis or an outpatient basis. It offers alcohol and drug residential detoxification and residential rehabilitation treatment services for up to 30 patients. The Labs and Life segment is commercializing proprietary epigenetic biomarker technology to be used for underwriting risk classification in the global life insurance industry.

Scores and Ratings
FRISK®
Score
Z''
Score
PAYCE®
Score
DBT
Index
Moody's
Rating
Fitch
Rating
DBRS
Rating
YesYes-----

Financials, News and Filings
Latest
Statement
Last
Audit

News
SEC
Filings
Bankruptcy
Filings
Suit &
Judgment
Filings
Tax
Lien
Filings
6/30/202412/31/2023YesYes--Yes

Officers and Directors

Title

Name

Age
Title
Date
Start
Date
Independent Chairman of the Board BretBarnes 41 11/15/2022 9/15/2022
Interim Chief Executive Officer, Director Mark K.White 63 9/19/2023 9/19/2023
Interim Chief Financial Officer Martin C.Ward 66 9/19/2023 9/19/2023
4 additional Officers and Directors records available in full report.

Subsidiaries
Business Name Address City State/Province Country
Genomas, Inc. 67 Jefferson Street Hartford CT United States
Rennova Health Inc 400 S. Australian Avenue, Suite 800 WEST PALM BEACH FL United States
Medytox Solutions Inc. 400 South Australian Ave., 8th Floor West Palm Beach FL United States
4 additional Subsidiary records available in full report.

Business Names
Business Name
Alethea Laboratories, Inc.
Big Fork South Medical Center.
Biohealth Medical Laboratory, Inc.
42 additional Business Names available in full report.

General Information
Number of Employees: 24 (As of 3/20/2023)
Outstanding Shares: 17,476,574 (As of 11/15/2024)
Shareholders: 60
Stock Exchange: ASE
Federal Tax Id: 851050265
Fax Number: (302) 636-5454


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Wednesday, November 20, 2024